MX377902B - Recubrimientos faciles de tragar y sustratos recubiertos con estos - Google Patents

Recubrimientos faciles de tragar y sustratos recubiertos con estos

Info

Publication number
MX377902B
MX377902B MX2019001238A MX2019001238A MX377902B MX 377902 B MX377902 B MX 377902B MX 2019001238 A MX2019001238 A MX 2019001238A MX 2019001238 A MX2019001238 A MX 2019001238A MX 377902 B MX377902 B MX 377902B
Authority
MX
Mexico
Prior art keywords
swallow
film coating
coating compositions
coatings
easy
Prior art date
Application number
MX2019001238A
Other languages
English (en)
Spanish (es)
Other versions
MX2019001238A (es
Inventor
Daniel To
Jason Teckoe
Jeffrey R Gimbel
Original Assignee
Bpsi Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bpsi Holdings Llc filed Critical Bpsi Holdings Llc
Publication of MX2019001238A publication Critical patent/MX2019001238A/es
Publication of MX377902B publication Critical patent/MX377902B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
MX2019001238A 2016-08-04 2017-07-26 Recubrimientos faciles de tragar y sustratos recubiertos con estos MX377902B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662370944P 2016-08-04 2016-08-04
PCT/US2017/043923 WO2018026596A1 (en) 2016-08-04 2017-07-26 Easy to swallow coatings and substrates coated therewith

Publications (2)

Publication Number Publication Date
MX2019001238A MX2019001238A (es) 2019-04-25
MX377902B true MX377902B (es) 2025-03-10

Family

ID=61071910

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019001238A MX377902B (es) 2016-08-04 2017-07-26 Recubrimientos faciles de tragar y sustratos recubiertos con estos

Country Status (11)

Country Link
US (1) US10232045B2 (enExample)
EP (1) EP3474824B1 (enExample)
JP (1) JP7041120B2 (enExample)
KR (1) KR102437953B1 (enExample)
CN (1) CN109562076B (enExample)
AU (1) AU2017307194B2 (enExample)
CA (1) CA3031671C (enExample)
CO (1) CO2019000756A2 (enExample)
MX (1) MX377902B (enExample)
RU (1) RU2753049C2 (enExample)
WO (1) WO2018026596A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113165338B (zh) * 2018-10-05 2023-04-11 埃斯普投资有限公司 包含水溶性纤维素醚的光滑的高固体膜包衣组合物及其制备工艺
EP3936581A4 (en) * 2019-03-04 2022-11-30 Sawai Pharmaceutical Co., Ltd. FILM COATING COMPOSITION AND SOLID PREPARATION
US11953458B2 (en) 2019-03-14 2024-04-09 Ecolab Usa Inc. Systems and methods utilizing sensor surface functionalization
US12427092B2 (en) 2020-11-05 2025-09-30 Purosil LLC Device and method for assisting pill swallowing

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543370A (en) 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
DE3220434A1 (de) 1982-05-29 1983-12-01 Robert Bosch Gmbh, 7000 Stuttgart Verfahren zur ueberwachung einer messgroesse
JP3165438B2 (ja) * 1990-04-04 2001-05-14 バーウィンド・ファーマス―ティカル・サーヴィスィーズ・インコーポレーテッド 水性のマルトデキストリン及びセルロースポリマーフィルムコーティング
US5114720A (en) * 1990-12-27 1992-05-19 American Cyanamid Company Gelatin coated tablets and method for producing same
WO2001026633A1 (en) 1999-10-11 2001-04-19 Monsanto Company Tablets coated with locust bean gum, guar gum or carrageenan gum
EP1753407B1 (en) * 2004-06-07 2017-03-08 Wyeth LLC Sugar coatings and methods therefor
EP2426151A1 (en) * 2006-07-20 2012-03-07 Rhodia, Inc. Method for making derivatized guar gum and derivatized guar gum made thereby
HUP0700826A3 (en) * 2007-12-20 2010-03-29 Richter Gedeon Nyrt Coated tablet containing drospirenone and process for producing the same
WO2009105409A2 (en) * 2008-02-19 2009-08-27 Mc Neil-Ppc, Inc. Dip coated compositions containing a starch having a high amylose content
WO2010052727A1 (en) * 2008-11-04 2010-05-14 Ideal Cures Private Limited High performance film coating compositions
US20100124568A1 (en) 2008-11-20 2010-05-20 Med-Eez, Inc Pharmaceutical articles coated with lubricious coatings
JP5795585B2 (ja) * 2009-08-28 2015-10-14 ハーキュリーズ・インコーポレーテッドHercules Incorporated 固体粉末化合物からのフィルムコーティング組成物
KR101767288B1 (ko) * 2010-03-31 2017-08-10 모찌다 세이야쿠 가부시끼가이샤 복용 용이성 고형 제제
US20120045510A1 (en) 2010-08-18 2012-02-23 Joel Waldman Tablet sleeve for improved performance
CN103402502A (zh) * 2011-02-14 2013-11-20 宝洁公司 包衣中包含蜂蜜的膜包衣固体剂型
EP3414983B1 (en) * 2011-02-28 2021-08-18 Rhodia Operations Seed coatings, coating compositions and methods for use
CN102652738A (zh) * 2011-03-03 2012-09-05 天津聚贤投资有限公司 便于吞咽的新型药物外包皮
HRP20170864T1 (hr) * 2011-06-01 2017-08-25 Fmc Corporation Čvrsti dozni oblici s kontroliranim oslobađanjem
US20130064889A1 (en) * 2011-09-13 2013-03-14 Aptapharma, Inc. Tablet-in-tablet Palperidone Formulations and Methods for Production and Use Thereof
CN107049979B (zh) * 2011-09-30 2020-08-14 持田制药株式会社 易服用性固体制剂
CN102430124B (zh) * 2011-11-24 2013-03-20 清华大学 一种具有超低摩擦系数的药丸涂层及其制备方法
CN104274409B (zh) * 2013-07-10 2017-11-03 北京科信必成医药科技发展有限公司 一种易于吞服的药物微球及其制备方法
CA2933202C (en) 2014-01-21 2022-05-31 Jason Teckoe Immediate release film coatings containing medium chain glycerides and substrates coated therewith
JP6294400B2 (ja) * 2016-07-19 2018-03-14 持田製薬株式会社 易服用性固形製剤

Also Published As

Publication number Publication date
RU2019105589A3 (enExample) 2020-09-04
CN109562076B (zh) 2022-01-28
KR102437953B1 (ko) 2022-08-29
EP3474824A1 (en) 2019-05-01
KR20190035745A (ko) 2019-04-03
WO2018026596A1 (en) 2018-02-08
US20180036413A1 (en) 2018-02-08
CO2019000756A2 (es) 2019-02-08
CN109562076A (zh) 2019-04-02
AU2017307194A1 (en) 2019-01-24
EP3474824B1 (en) 2022-02-16
JP2019523290A (ja) 2019-08-22
RU2753049C2 (ru) 2021-08-11
AU2017307194B2 (en) 2022-06-23
RU2019105589A (ru) 2020-09-04
US10232045B2 (en) 2019-03-19
EP3474824A4 (en) 2019-07-31
JP7041120B2 (ja) 2022-03-23
CA3031671A1 (en) 2018-02-08
CA3031671C (en) 2024-10-29
BR112019002040A2 (pt) 2019-05-07
MX2019001238A (es) 2019-04-25

Similar Documents

Publication Publication Date Title
BR112015020836A2 (pt) revestimentos de filme de liberação retardada que contêm silicato de cálcio e substratos revestidos com os mesmos
CO2019000756A2 (es) Recubrimientos fáciles de tragar y sustratos recubiertos con estos
BR112015025015A2 (pt) composições de formação de película para o revestimento com película de formas sólidas
BRPI1007724A2 (pt) Composição de revestimento seco, suspensão aquosa, substrato oral, método para preparação de dispersão aquosa de revestimento, forma de dosagem oral farmaceuticamente aceitável e método de preparação de formas de dosagem sólidas orais farmaceuticamente aceitáveis
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
BR112017015696A2 (pt) ?método para preparar uma folha de metal, folha de metal e uso de uma solução aquosa?
MX376356B (es) Método para producir un material de embalaje revestido y material de embalaje con al menos una capa barrera para los compuestos hidrófobos.
BR112017012363A8 (pt) Microcápsulas revestidas, seu uso e produto de consumo que as compreende
BR112015030140A2 (pt) forma de dosagem farmacêutica sólida para liberação de pelo menos um ingrediente farmacêutico ativo na cavidade oral
MX2016008583A (es) Revestimientos de pelicula de liberacion inmediata que contienen gliceridos de cadena media y sustratos revestidos con los mismos.
BR112014032793A2 (pt) métodos e meios para revestimento de papel por revestimento de película
MX385134B (es) Composición acuosa para recubrimiento de superficies y partículas modificadas.
BR112014010116A8 (pt) métodos para a aplicação de um revestimento a um substrato em forma cilíndrica
BR112018015647A2 (pt) composição aquosa de revestimento de componente único, película de polímero, embalagem, método para formação de película polimérica, e, uso de uma composição.
BR112012010237A2 (pt) sistema de revestimento de um componente, emprego do mesmo e marcação de estradas
BR112019003173A2 (pt) formulação farmacêutica, uso de uma formulação farmacêutica e método para evitar o aumento da viscosidade durante o armazenamento de uma formulação farmacêutica
AR104710A1 (es) Método para producir un recubrimiento multicapa
BR112018070084A2 (pt) composições de célula viável, e métodos relacionados às mesmas
BR112018003617A2 (pt) adesivo não aquoso compreendendo lidocaína e método para administrar referido adesivo
BR112015020237A2 (pt) comprimido com revestimento entérico
CL2009001062A1 (es) Mezcla de barniz para revestir una forma farmaceutica de dosificacion solida que comprende a) agua (80 a 99% del peso total), b) un agente formador de pelicula (0,25 a 20% del peso total), y c) un agente de revestimiento (0,01 a 5% del peso total;) proceso de barnizado; forma farmaceutica solida .
BR112023013880A2 (pt) Revestimentos de alta opacidade e substratos revestidos com os mesmos
BR112019003673A2 (pt) formulação farmacêutica, uso de uma formulação farmacêutica e método para evitar o aumento da viscosidade durante o armazenamento de uma formulação farmacêutica
BR112016028321A2 (pt) método, composição de revestimento, propágulo, kit
MX2021004418A (es) Derivados de 4 pirazin 2 ilmetil-morfolina y su uso como medicamento.